Healthcare
Live Price
Offline$5.00
+4.17% today
1Y Change
+82.48%
Window
Jun 25, 2025 โ Jun 18, 2026
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Clover Health Investments, Corp. (CLOV) is a Healthcare stock with a market cap of $1.34B and listed on NASDAQ. The stock last traded around $5.00 and up 82.5% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +40.3%, EPS growth of -93.6%, a dividend yield of 0.0%. What stands out right now is revenue +40.3%, EPS -93.6%, free cash flow -307.2% with operating margin -4.4% and ROIC -25.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.7. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines CLOV price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+40.3% vs +7.6% peer median
Operating Margin
Below sector median
-4.4% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +40.3% and EPS is at -93.6%, with operating margin around -4.4%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -1.9% over the next 5 trading days and finished higher after 1 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | โ | +2.7% | +25.7% | +39.8% |
2026 Feb 26, 2026 | +51.0% | -2.8% | -3.7% | -16.3% |
2025 Nov 4, 2025 | -350.0% | -15.8% | -27.6% | -25.6% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CLOV
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CLOV Max Drawdown
-55.50%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for CLOV and SPY.
Company Overview
Clover Health Investments, Corp.
NASDAQ
Clover Health Investments, Corp. is a healthcare technology company that provides Medicare Advantage plans in the United States. Its primary focus is empowering physicians to proactively manage chronic diseases among Medicare-eligible individuals through its proprietary software platform, Clover Assistant. This cloud-based tool aggregates patient data from the healthcare ecosystem, delivering personalized insights for early detection, identification, and management of conditions to support clinical decision-making and improve health outcomes. The company operates in the insurance segment, offering preferred provider organization (PPO) and health maintenance organization (HMO) plans, with an emphasis on wide-network, high-choice PPO options available in several states. Clover Health Investments, Corp. integrates technology-driven preventive care into its offerings, positioning it as a key player in value-based healthcare within the Medicare Advantage market. Founded in 2014 and headquartered in Wilmington, Delaware, it serves members seeking enhanced, data-informed medical experiences.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.